Disclosures for "DMT use in Cluster Headache: Interim Analysis of an International Survey"
-
Dr. Schindler has received intellectual property interests from a discovery or technology relating to health care.
-
Mr. Lenaburg has stock in Lobe Sciences Ltd. Mr. Lenaburg has received personal compensation in the range of $10,000-$49,999 for serving as a Policy Director with Clusterbusters.
-
Mr. Wold has received personal compensation for serving as an employee of Clusterbusters, Inc. Mr. Wold has a non-compensated relationship as a Executive Director with Clusterbusters, Inc that is relevant to AAN interests or activities. Mr. Wold has a non-compensated relationship as a Board Member with Alliance for HEadache Disorders Advocay that is relevant to AAN interests or activities. Mr. Wold has a non-compensated relationship as a Board member with Psychedelics & Pain Association that is relevant to AAN interests or activities. Mr. Wold has a non-compensated relationship as a Participant with CHAMP that is relevant to AAN interests or activities.